FIGS vs. Gildan Activewear: Which Consumer Stock Is a Better Buy in 2026?
One company powers healthcare apparel with direct sales and rapid growth, while the other scales global basics with steady cash flow and lower valuations.
FIGS vs. Gildan Activewear: Which Consumer Stock Is a Better Buy in 2026?
Overview
Choosing between growth and stability often defines a portfolio strategy. In 2026, comparing the specialist scrubs brand FIGS (NYSE:FIGS) against the vertically integrated giant Gildan Activewear (NYSE:GIL) highlights two very different ways to win.
FIGS focuses on a specific niche of healthcare professionals, aiming to disrupt a traditionally stale, uniform market by building brand loyalty. In contrast, Gildan Activewear produces large volumes of basics, such as T-shirts and fleece, for wholesalers and retail brands. Both companies are prominent players among apparel stocks, yet they offer distinct risk profiles.
Details
FIGS operates as a specialist in the apparel stocks category, selling technically advanced scrubs directly to healthcare professionals. The company uses a direct-to-consumer model to build brand loyalty through digital marketing and its TEAMS platform for healthcare institutions. By March 2026, the company served more than 3 million active customers across the United States and several international markets.
Source
Originally published at www.fool.com.
